Nicontrol Menta (Nicotine)

Nicotine, the active ingredient in Nicontrol Menta, is a nicotine replacement therapy presented as an oromucosal dosage form for oromucosal use. It helps adult smokers who wish to quit by reducing nicotine withdrawal symptoms and cravings.

GNH USA supplies Nicontrol Menta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets. The company provides reliable sourcing, documentation and logistics support for global healthcare providers.

Nicontrol Menta is used as a nicotine replacement therapy to address nicotine dependence and support smoking cessation. - Smoking cessation: assists adult smokers in reducing cravings and withdrawal symptoms during quit attempts. - Nicotine dependence: provides controlled nicotine exposure to facilitate gradual reduction of tobacco use. - Tobacco use disorder: supports behavioral cessation programs by delivering a regulated nicotine dose. - Relapse prevention: helps maintain abstinence after the initial quitting phase.

Nicontrol Menta may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation or soreness - Nausea or upset stomach - Hiccups or throat discomfort - Headache - Dizziness - Increased salivation

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Cardiovascular events (palpitations, hypertension) - Severe nausea or vomiting - Respiratory difficulty - Seizures (rare) - Cardiac arrhythmia

When using Nicontrol Menta, consider the following precautions to ensure safe and effective use. - Assess nicotine dependence level: determine appropriate initiation and titration. - Avoid use in children and adolescents: not approved for individuals under 18 years. - Monitor for cardiovascular disease: use cautiously in patients with hypertension or arrhythmias. - Do not use concomitantly with other nicotine products: risk of nicotine overdose. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Nicontrol Menta can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Concurrent use of monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Combining with other nicotine delivery systems (patches, gums): risk of nicotine toxicity. - Use with certain psychiatric medications (e.g., bupropion) without monitoring: may potentiate side effects.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., some antitubercular drugs): may alter nicotine metabolism. - Alcohol consumption: may increase nicotine absorption and side effects. - Use with antihypertensive drugs: nicotine may counteract blood pressure‑lowering effect.